Business & Finance
Bactiguard Holding widens loss in Q3 2018
7 November 2018 -

Bactiguard Holding AB (Bactiguard)(STO:BACTIB), a Swedish medical device company, reported on Tuesday net loss of SEK0.5m, or SEK0.02 per share, for the third quarter of 2018, from July 2018 to September 2018.

This was a decline over net loss of SEK 0.4m, or SEK0.01 per share, in Q3 2017.

Revenues for the quarter amounted to SEK35.7m, up by 3% as compared with SEK34.8m in Q3 2017.

BIP (Bactiguard Infection Protection) sales for the quarter amounted to SEK3.9m, down by 24% as compared with SEK5.2m in Q3 2017, which is explained by the fact that this quarter did not contain any deliveries to China, as compared with Q3 2017.

Bactiguard develops and supplies infection protection solutions, which reduce the risk of healthcare associated infections and the use of antibiotics.